IRIS
BRUNETTI, ORONZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.424
AS - Asia 1.595
EU - Europa 1.209
SA - Sud America 416
AF - Africa 72
OC - Oceania 3
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.721
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.359
SG - Singapore 649
IT - Italia 390
CN - Cina 333
BR - Brasile 324
SE - Svezia 225
HK - Hong Kong 202
RU - Federazione Russa 159
VN - Vietnam 136
FR - Francia 103
DE - Germania 92
GB - Regno Unito 78
IN - India 62
FI - Finlandia 50
AR - Argentina 39
CA - Canada 31
ID - Indonesia 30
TR - Turchia 27
BD - Bangladesh 25
BE - Belgio 25
ZA - Sudafrica 20
PL - Polonia 17
CI - Costa d'Avorio 15
CO - Colombia 15
PK - Pakistan 15
IQ - Iraq 14
MX - Messico 14
JP - Giappone 12
EC - Ecuador 11
ES - Italia 11
UA - Ucraina 11
UZ - Uzbekistan 11
MA - Marocco 10
VE - Venezuela 10
AE - Emirati Arabi Uniti 9
CZ - Repubblica Ceca 9
MY - Malesia 7
PH - Filippine 7
CL - Cile 6
ET - Etiopia 6
IL - Israele 6
IR - Iran 6
JO - Giordania 6
CH - Svizzera 5
KE - Kenya 5
PY - Paraguay 5
AT - Austria 4
EG - Egitto 4
JM - Giamaica 4
KR - Corea 4
KZ - Kazakistan 4
NL - Olanda 4
NP - Nepal 4
SA - Arabia Saudita 4
AU - Australia 3
BO - Bolivia 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
IE - Irlanda 3
KW - Kuwait 3
LT - Lituania 3
PS - Palestinian Territory 3
TN - Tunisia 3
AL - Albania 2
AO - Angola 2
AZ - Azerbaigian 2
BH - Bahrain 2
CR - Costa Rica 2
DK - Danimarca 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MM - Myanmar 2
MU - Mauritius 2
NI - Nicaragua 2
QA - Qatar 2
RS - Serbia 2
SV - El Salvador 2
UY - Uruguay 2
AQ - Antartide 1
BB - Barbados 1
BG - Bulgaria 1
BJ - Benin 1
DZ - Algeria 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
KY - Cayman, isole 1
LU - Lussemburgo 1
MD - Moldavia 1
MT - Malta 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
Totale 7.714
Salva come PNG Salva come JPEG
Città #
Fairfield 519
Ashburn 513
Chandler 443
Singapore 371
Woodbridge 282
Seattle 251
Cambridge 220
Houston 213
Milan 203
Hong Kong 198
Nyköping 182
San Jose 179
Wilmington 171
Beijing 111
Ann Arbor 109
Dearborn 103
Dallas 74
New York 73
Lawrence 57
Roxbury 55
Los Angeles 54
Lauterbourg 51
Rome 51
Council Bluffs 46
Ho Chi Minh City 42
Munich 41
Brooklyn 40
Des Moines 36
São Paulo 32
Santa Clara 30
The Dalles 30
Boardman 29
Nanjing 29
Helsinki 26
San Diego 25
Brussels 24
Columbus 24
Dong Ket 24
Moscow 24
Hanoi 22
Jakarta 22
Bari 19
Turku 19
Paris 17
Frankfurt am Main 16
Abidjan 15
Inglewood 15
Montreal 15
Chennai 14
Hefei 14
Figino 13
Pune 13
Turin 13
Warsaw 13
Chicago 12
Da Nang 12
London 12
Orem 12
Phoenix 12
Tokyo 12
Buffalo 11
Denver 11
Marseille 11
Shanghai 10
Johannesburg 9
Stockholm 9
Tashkent 9
Belo Horizonte 8
Guangzhou 8
Jinan 8
Lahore 8
Manchester 8
Poplar 8
Rio de Janeiro 8
San Francisco 8
San Mateo 8
Atlanta 7
Düsseldorf 7
Mumbai 7
Naples 7
Nuremberg 7
Amman 6
Augusta 6
Brno 6
Campinas 6
Curitiba 6
Dhaka 6
Edinburgh 6
Jacksonville 6
Washington 6
Addis Ababa 5
Baghdad 5
Blumenau 5
Kilburn 5
Kunming 5
Monmouth Junction 5
Princeton 5
Salvador 5
Toronto 5
Zhengzhou 5
Totale 5.578
Salva come PNG Salva come JPEG
Nome #
Mast cells and angiogenesis in pancreatic ductal adenocarcinoma 255
Angiogenesis in adenosquamous cancer of pancreas 226
Angiogenesis in pancreatic ductal adenocarcinoma: A controversial issue 192
CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer 192
Emerging role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma 191
Fisiologia V Ed. 185
Everolimus restrains the paracrine pro-osteoclast activity of breast cancer cells 177
Targeting angiogenesis in biliary tract cancers: An open option 173
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview 173
Bone metastasis as primary presentation of pancreatic ductal adenocarcinoma: A case report and literature review 173
Inflammatory cells infiltrate and angiogenesis in locally advanced and metastatic cholangiocarcinoma 172
Multicenter prospective study of angiogenesis polymorphism validation in HCC patients treated with sorafenib. An INNOVATE study protocol 163
Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma 162
Systematic review of irreversible electroporation role in management of locally advanced pancreatic cancer 162
Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinoma 161
Bone metastases in biliary cancers: A multicenter retrospective survey 161
Antiangiogenic agents after first line and sorafenib plus chemoembolization: A systematic review 160
Effects of metformin on clinical outcome in diabetic patients with advanced HCC receiving sorafenib 157
Role of miR-27a, miR-181a and miR-20b in gastric cancer hypoxia-induced chemoresistance 153
Strategies to improve cancer immune checkpoint inhibitors efficacy, other than abscopal effect: A systematic review 153
Potential predictive role of chemotherapy-induced changes of soluble CD40 ligand in untreated advanced pancreatic ductal adenocarcinoma 149
Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: A retrospective study 147
Micro-RNA in pancreatic adenocarcinoma: Predictive/prognostic biomarkers or therapeutic targets? 139
Validation of a Simple Scoring System to Predict Sorafenib Effectiveness in Patients with Hepatocellular Carcinoma 138
Systemic chemotherapy for advanced rare pancreatic histotype tumors: A retrospective multicenter analysis 137
Cytotoxic t-lymphocyte antigen-4 in colorectal cancer: Another therapeutic side of capecitabine 137
Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib 136
Multimodal treatment of resectable pancreatic ductal adenocarcinoma 136
Long‐term survival of an advanced colorectal cancer patient treated with Regorafenib: Case report and literature review 135
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy 135
Molecular characterization of a long-term survivor double metastatic non-small cell lung cancer and pancreatic ductal adenocarcinoma treated with gefitinib in combination with gemcitabine plus nab-paclitaxel and mFOLFOX6 as first and second line therapy 131
Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials 126
Immunotherapy for colorectal cancer: where are we heading? 124
Second-line chemotherapy for advanced pancreatic cancer: Which is the best option? 124
COVID-19 Infection in Cancer Patients: How Can Oncologists Deal With These Patients? 120
The potential predictive role of nuclear NHERF1 expression in advanced gastric cancer patients treated with epirubicin/oxaliplatin/capecitabine first line chemotherapy 118
Management of patients with end-stage renal disease undergoing chemotherapy: Recommendations of the Associazione Italiana di Oncologia Medica (AIOM) and the Società Italiana di Nefrologia (SIN) 117
The Immune Revolution in Gastrointestinal Tumours: Leading the Way or Just Following? 117
Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors 116
Bone metastases in hepatocellular carcinoma: an emerging issue 116
Immunological mutational signature in adenosquamous cancer of pancreas: an exploratory study of potentially therapeutic targets 109
Basics and frontiers on pancreatic cancer for radiation oncology: Target delineation, SBRT, SIB technique, MRgRT, particle therapy, immunotherapy and clinical guidelines 107
Expression and characterization of a novel recombinant cytotoxin II from Naja naja oxiana venom: A potential treatment for breast cancer 104
Somatic BRCA Mutation in a Cholangiocarcinoma Patient for HBOC Syndrome Detection 104
Clinical practice guidelines for diagnosis, treatment and follow-up of exocrine pancreatic ductal adenocarcinoma: Evidence evaluation and recommendations by the italian association of medical oncology (AIOM) 101
Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations 98
A scoping review on the potentiality of PD-L1-inhibiting microRNAs in treating colorectal cancer: Toward single-cell sequencing-guided biocompatible-based delivery 97
Complete Response of Synchronous Liver Metastasis in a Pancreatic Ductal Adenocarcinoma: Could Surgery Represent a Therapeutic Option? 96
Immune system and bone microenvironment: rationale for targeted cancer therapies 95
Paraneoplastic focal segmental glomerulosclerosis in sarcomatoid renal cell cancer. 95
NLRP3 Inflammasome From Bench to Bedside: New Perspectives for Triple Negative Breast Cancer 84
Role of BRAF in Hepatocellular Carcinoma: A Rationale for Future Targeted Cancer Therapies 83
The latest findings of PD-1/PD-L1 inhibitor application in gynecologic cancers 82
null 81
null 67
Second-line treatments for Advanced Hepatocellular Carcinoma: A Systematic Review and Bayesian Network Meta-analysis 67
null 61
Is it Time for a Therapeutic Algorithm in Resected Pancreatic Ductal Adenocarcinoma? 61
Hepatocellular carcinoma treatment over sorafenib: epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel? 57
Moving the target on the optimal adjuvant strategy for resected pancreatic cancers: A systematic review with meta-analysis 51
On the Management of Drug Interactions in the Course of Concomitant Treatments for COVID-19 and Antineoplastic Agents 50
The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead 48
Identification of Common and Distinct Pathways in Inflammatory Bowel Disease and Colorectal Cancer: A Hypothesis Based on Weighted Gene Co-Expression Network Analysis 17
Totale 7.954
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.571
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.571
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022509 42 19 13 15 20 45 17 30 37 46 68 157
2022/2023929 104 155 85 75 85 95 15 113 140 5 40 17
2023/2024324 19 59 15 28 33 95 7 9 3 7 3 46
2024/20251.210 53 11 85 51 47 111 103 107 44 79 197 322
2025/20262.612 405 115 168 281 326 124 258 80 272 215 63 305
2026/202755 55 0 0 0 0 0 0 0 0 0 0 0
Totale 7.954